Role of Cardiac AngioMR in Diagnosis of Cardiac and Vascular Anomalies in Adult Patients with Turner Syndrome
Launched by AZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA · Dec 11, 2023
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of Clinical Trial: Role of Cardiac AngioMR in Diagnosing Heart Problems in Adults with Turner Syndrome**
This clinical trial is looking at how a special type of heart imaging, called Cardiac AngioMR, can help doctors find heart and blood vessel issues in women with Turner Syndrome. Turner Syndrome is a genetic condition that can lead to various health problems, including heart disease. The researchers want to see if this imaging technique can provide better information about not only the heart but also the lower parts of the blood vessels in the abdomen, which previous studies have not explored.
To take part in this trial, women must be over 18 years old and have a confirmed diagnosis of Turner Syndrome. Participants will undergo a Cardiac AngioMR procedure, which is a non-invasive test that uses magnets and radio waves to create detailed images of the heart and blood vessels. This trial is currently recruiting participants, so if you or someone you know meets the criteria, it could be a valuable opportunity to contribute to important research that may improve care for others with Turner Syndrome in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • confirmed diagnosis of Turner Syndrome
- • patients underwent angioMR 1.5 T
- • age \> 18 years
About Azienda Ospedaliero Universitaria Di Modena
Azienda Ospedaliero-Universitaria di Modena is a prominent healthcare institution in Italy, renowned for its commitment to excellence in patient care, medical research, and education. As a leading clinical trial sponsor, it integrates advanced medical practices with innovative research methodologies to drive the development of new therapies and improve health outcomes. The institution collaborates with a diverse range of stakeholders, including academic partners and pharmaceutical companies, to facilitate cutting-edge clinical trials across various therapeutic areas. With a focus on patient safety and ethical standards, Azienda Ospedaliero-Universitaria di Modena plays a pivotal role in advancing medical knowledge and enhancing the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Modena, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported